PLUN.ST
ProstaLund AB (publ) [PLUN.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PLUN.ST Stock Summary
In the News
PLUN.ST Financial details
Company Rating
-
Market Cap
78.89M
Income
-17.01M
Revenue
22.21M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
03 May 2024
P/E
-7.47
Forward P/E
-
PEG
-4.26
P/S
5.88
P/B
2.13
P/C
-
P/FCF
-5.34
Quick Ratio
2.55
Current Ratio
4.66
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.25
EPS next Y
-
EPS next Q
-
EPS this Y
19.05%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.28%
Revenue last 5Y
11.5%
Revenue Q/Q
33.87%
EPS Q/Q
-46.1%
-
-
-
-
SMA20
3.13%
SMA50
-15.29%
SMA100
-25.54%
Inst Own
-
Inst Trans
-
ROA
-24%
ROE
-33%
ROC
-0.28%
Gross Margin
70%
Oper. Margin
-78%
Profit Margin
-79%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.994-3.965934
52W High
-
52W Low
-
RSI
54.91
Rel Volume
0.03
Avg Volume
78.59K
Volume
2.28K
Perf Week
0.67%
Perf Month
27.12%
Perf Quarter
-37.5%
Perf Half Y
-27.04%
-
-
-
-
Beta
0.793
-
-
Volatility
0.16%, 0.41%
Prev Close
1.35%
Price
7.5
Change
8.7%
Company Profile
- Volume Average 78.59K
- Market Capitalization 78.89M
- Employee 7
- CEO Mr. Johan Wennerholm
- Headquarters Lund,SE
- IPO Date 2013-10-25
-
Website
https://www.prostalund.se 
ProstaLund AB (publ) develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) in Sweden and internationally. The company also offers CoreTherm, a heat treatment of BPH; and Gepan instill for the treatment of chronic bladder inflammation. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
